Amiksin – low molecular weight synthetic inducer of interferon, which stimulates the body’s production of interferon alpha, beta and gamma. Major producers of interferon in response to tilorona are intestinal epithelial cells, hepatocytes, T-lymphocytes, neutrophils, and granulocytes. After ingestion maximum production of interferon is defined in the sequence intestine – liver – blood through 4-24 hours.
Amixin® possesses immunomodulatory and antiviral effects.
In human leukocytes induces the synthesis of interferon. Stimulates bone marrow stem cells, dose-dependently enhances antibody production, reduces the degree of immunosuppression, restores ratio T-suppressor and T-helper cells.
It is effective against a variety of viral infections, including influenza virus, and other acute respiratory viral infections, hepatitis viruses and herpes viruses. antiviral mechanism of action is associated with inhibition of translation of virus-specific proteins in infected cells, resulting in suppressed reproduction of viruses.
After intake of rapidly absorbed from the gastrointestinal tract. Bioavailability – 60%. About 80% of the drug is bound to plasma proteins. Displayed drug virtually unchanged through the gut (70%) and the kidneys (9%). The half-life (T1 / 2) -. Preparation 48 hours no biotransformation and does not accumulate in the body.